Status:
UNKNOWN
Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Takayasu Arteritis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Takayasu arteritis associated renal artery stenosis (TARAS) is the biggest cause of hypertension in young people \<40 years old. Hypertension caused by renal artery stenosis is usually hard to control...
Eligibility Criteria
Inclusion
- 18-60 years old;
- diagnosed as Takayasu arteritis according to 1990 ACR classification
- renal artery stenosis is confirmed by imaging results
- had inactive disease, and the dose of glucocorticoids \<10mg/day
- blood pressure \>160/90mmHg in spite of two or more antihypertensive drug
- had no surgery of renal artery, including PTA, stent, or others.
Exclusion
- blood pressure \>200/120mmHg in spite of two or more antihypertensive drug
- had severe disease conditions
- allergy to contrast agent
- had other autoimmune disease
- had severe abnormal lab test result
Key Trial Info
Start Date :
November 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04137614
Start Date
November 30 2019
End Date
November 30 2022
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lindi Jiang
Shanghai, Shanghai Municipality, China, 200032